Annemarie T. Swaak‐Kragten
Papers
1
Total Citations
7
H-Index
1
About
Annemarie T. Swaak‐Kragten is a leading researcher in radiation oncology, with a primary focus on optimizing treatment planning to minimize long-term risks for breast cancer patients. Her most cited work, "Reducing the Risk of Secondary Lung Cancer in Treatment Planning of Accelerated Partial Breast Irradiation" (2020, 7 citations), addresses a critical clinical challenge: while accelerated partial breast irradiation (APBI) offers excellent local control for low-risk breast cancer, the survival benefit can be partially offset by radiation-induced secondary lung cancers. Swaak‐Kragten demonstrates how strategic dose reduction to the lung during APBI planning can significantly lower this risk, providing a practical framework for safer radiotherapy. Her research bridges the gap between treatment efficacy and late toxicity, offering actionable insights for clinicians. Though her citation count is modest, the clinical relevance of her work is substantial, influencing treatment protocols that prioritize both cancer control and patient quality of life. Swaak‐Kragten’s contributions underscore a vital shift in oncology: moving beyond tumor eradication to holistic, risk-adapted care.
Research Focus
Key Achievements
Top Papers
- 1